LASA SUPERGENERICS
Back to Income Statement
|
LASA SUPERGENERICS Last 5 Year Operating Profit History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹2.22 Cr | ₹-6.60 Cr | ₹16 Cr | ₹47 Cr | ₹30 Cr |
What is the latest Operating Profit of LASA SUPERGENERICS ?
| Year | Operating Profit |
|---|---|
| Mar2024 | ₹2.22 Cr |
| Mar2023 | ₹-6.60 Cr |
| Mar2022 | ₹16 Cr |
| Mar2021 | ₹47 Cr |
| Mar2020 | ₹30 Cr |
How is Operating Profit of LASA SUPERGENERICS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹2.22 Cr | Positive | |
| Mar2023 | ₹-6.60 Cr | Negative | |
| Mar2022 | ₹16 Cr | -66.07 | |
| Mar2021 | ₹47 Cr | 57.53 | |
| Mar2020 | ₹30 Cr | - | |
Compare Operating Profit of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹47.0 Cr | -0.2% | 2.7% | -64.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -2.8% | -7.5% | -12.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | -0.6% | -5.5% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -2.5% | 3.5% | 21.1% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3.7% | -11.7% | -8.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | -0.7% | -4.7% | -5.1% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -0.2% |
2.7% |
-64.3% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses